bavituximab MeSH Supplementary Concept Data 2025

Details
Concepts

MeSH Supplementary: bavituximab
Unique ID: C547825
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C547825
Entry Term(s): CH3G4; Tarvacin
Pharm Action: Antineoplastic Agents, Immunological
Registry Numbers: Q16CT95N25
Heading Mapped to: *Antibodies, Monoclonal
Frequency: 20
Note: in clinical trials as an antineoplastic agent (2007)
Source: Clin Cancer Res 2007 Sep 1;13(17):5211-8
Date of Entry: 2010/03/17
Revision Date: 2019/10/31

bavituximab Preferred

Tarvacin Narrower

CH3G4 Narrower

page delivered in 0.005s